시장보고서
상품코드
1901522

말 헬스케어 시장 : 제품별, 적응증별, 활동별, 유통 채널별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 점유율, 예측(2025-2032년)

Equine Healthcare Market, By Product, By Indication, By Activity, By Distribution Channel, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 365 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

말 헬스케어 시장 규모는 2024년 33억 4,567만 달러로 평가되었으며, 2025년부터 2032년까지 연평균 복합 성장률(CAGR) 8.4%를 나타낼 전망입니다.

말 헬스케어 서비스에는 경주와 도박, 승마 경기, 레저 목적으로 사육되는 말에 대한 의료가 포함됩니다. 정기적인 수의사 진찰에 의한 예방접종, 기생충 대책, 치과 치료에 가세해, 그루밍, 발굽의 손질, 비·바람·눈 등의 날씨로부터의 보호도 포함됩니다. 말을 건강하게 평생 사육하기 위해서는 적절한 먹이와 운동만으로는 충분하지 않습니다. 일반적인 케어의 일환으로 다른 대응도 필요합니다. 나리마는 적어도 일년에 한 번 수의사가 종합적인 건강검진을 받아야 합니다. 20세 이상의 말은 1년에 2회 이상, 컨디션 불량의 경우는 보다 자주 수의사의 진찰을 받아야 합니다. 노인 동물은 질병에 걸리기 쉽고 조기 발견이 쉽기 때문입니다.

말 헬스케어 시장 역학

승마 스포츠 참여 증가

승마를 즐기는 분이 늘어나면서 말의 건강과 퍼포먼스에 대한 주목이 높아져, 말 헬스케어 시장은 이 동향의 혜택을 받고 있습니다. 경주, 바바마술, 장애비월경기 등의 활동에 참가하는 개인이 많을수록 전문적인 헬스케어 용품과 서비스 수요도 확대됩니다. 참가마에 대한 종합적인 헬스케어 계획을 요구하는 마술 이벤트나 경기회도 증가 경향에 있습니다. 이 동향이 확대되고 있음을 알 수 있습니다. 이러한 이유로 말주가 말의 건강과 성과를 최우선으로 함에 따라 말 헬스케어 시장은 성장할 것으로 예측됩니다. 영국 승마 연맹(British Equestrian)에 따르면 정기적인 승마자는 182만명, 가끔 승마하는 사람은 320만명, 말의 머리는 85만, 산업 규모는 66억 달러에 이릅니다.

말 헬스케어 시장 : 세분화 분석

세계 시장은 제품, 적응증, 활동, 유통 채널, 지역에 따라 시장 세분화됩니다.

제품별로는 의약품 부문이 예측 기간 동안 최대 시장 점유율을 획득할 것으로 예측됩니다. 치료제, 예방약, 특수약에 대한 수요가 높아지면서 시장은 확대 경향이 있습니다. 말의 질병에 대한 주인의 인식 향상, 수의사가 처방하는 치료법의 수용도 향상, 치료비의 지불 의향 증가가 시장의 급속한 성장을 뒷받침하고 있습니다. 항생제, 항염증제, 진통제, 백신 접종 등 동물의 건강 증진과 기능 향상에 기여하는 제품은 다양합니다. 주요 제약 기업은 말 헬스케어 사업의 확대책으로서 연구 개발, 신규 약제의 창조, 전략적 제휴를 최우선 과제로 자리 매김하고 있습니다. 바이오의약품, 재생의료, 개인화 치료의 진보로 시장에서는 부문별 수익성장이 전망되고 있습니다.

적응증별로, 기생충 감염 부문은 예측 기간 동안 시장을 독점합니다. 말에 있어서의 내부·외부 기생충의 고빈도 발생이 시장 성장을 견인하고 있습니다. 강충, 조충, 진드기 등의 기생충은 통증, 빈혈, 체중 감소 등 심각한 건강 문제를 일으키기 때문에 효과적인 구충제 수요는 여전히 높은 수준에 있습니다. 편의성과 효능을 향상시키기 위해 장시간 작용제, 병용 요법, 개선된 제제가 점점 활용되고 있습니다.

말 헬스케어 시장 - 지역별 분석

북미는 2024년 시장 점유율의 대부분을 차지했으며 예측 기간 동안에도 비슷한 경향이 지속될 것으로 전망됩니다. 복지 지출, 승용마의 보급, 진단 기술 및 재생 의료의 진보가 업계 성장을 뒷받침하고 있습니다. 이 지역의 말 건강과 복지에 관한 규제 강화도 향후 발전에 기여할 것으로 예측됩니다. 미국 농무부(USDA)의 동식물 위생 검사국(APHIS)은 2024년 5월 말 보호 규제를 강화하고 의도적인 말 소어링 행위를 금지했습니다. 말주가 경주 등의 경기 성적 향상을 위해 말에 고의로 상처를 입히는 행위입니다만, 말의 건강에 악영향을 미칠 가능성이 있습니다.

미국의 말 헬스케어 시장 - 국가별 분석

미국은 해당 지역 시장을 주도하고 있습니다. 이 성장은 고도의 수의약·진단기술·소프트웨어 서비스에 대한 수요 증가에 더해, 마주·번식업자·마술 경기 관계자의 문제 의식의 고조와 예방책의 실시 등, 여러 요인에 의한 것입니다. 또한 말전문병원 인수 증가가 업계 성장을 가속할 것으로 전망됩니다. 예를 들면, 2025년 4월에는 수의학의 최첨단을 가는 국제적인 말 전문 클리닉 네트워크를 운영하는 알타노 그룹이 델 오에스테 말 병원의 인수를 발표했습니다.

목차

제1장 말 헬스케어 시장 개요

  • 분석 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 말 헬스케어의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 말 헬스케어 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 매핑
  • 규제 체계 분석

제5장 말 헬스케어 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아·우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 말 헬스케어 시장 상황

  • 말 헬스케어 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신생 기업 분석

제7장 말 헬스케어 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 제약
    • 백신
    • 의약용 사료 첨가제
    • 정형외과 생물학적 제제
    • 진단제
    • 소프트웨어 및 서비스
    • 기타

제8장 말 헬스케어 시장 : 적응증별

  • 개요
    • 부문별 점유율 분석 : 적응증별
    • 말 헤르페스 바이러스
    • 근골격계 장애
    • 기생충 감염
    • 말 인플루엔자
    • 말 바이러스성 동맥염(EVA)
    • 파상풍
    • 웨스트 나일 바이러스
    • 기타

제9장 말 헬스케어 시장 : 활동별

  • 개요
    • 부문별 점유율 분석 : 활동별
    • 스포츠 및 경주
    • 레크리에이션
    • 기타

제10장 말 헬스케어 시장 : 유통 채널별

  • 개요
    • 부문별 점유율 분석 : 유통 채널별
    • 동물 병원 및 진료소
    • 승마시설
    • 전자상거래
    • 기타

제11장 말 헬스케어 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제12장 주요 공급업체 분석 : 말 헬스케어 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 프로파일
    • Arthrex Inc.
    • Zoetis Services LLC
    • Cargill
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Heska Corporation
    • Merck &Co. Inc
    • Esaote SPA
    • Dechra
    • Covetrus Inc.
    • Elanco
    • IDEXX Laboratories, Inc.
    • Equine Care Group
    • Boehringer Ingelheim Animal Health USA Inc.
    • Merck Animal Health

제13장 애널리스트의 전방위적 전망

KTH

The equine healthcare Market size was valued at US$ 3,345.67 Million in 2024, expanding at a CAGR of 8.4% from 2025 to 2032.

Equine healthcare includes services for horses that race and wager, compete in riding, and have fun. Healthcare includes regular trips to the vet for vaccinations, parasite control, and dental care. It also includes grooming, hoof care, and protection from the elements, including rain, wind, and snow. To keep a horse healthy for life, it's necessary to do more than just feed and exercise it properly. One also needs to do other things that are part of general care. At least once a year, adult horses should see a veterinarian for a comprehensive check-up. Horses over the age of 20 should see their vet at least twice a year, and more often if they are unwell. This is because older animals are more likely to get sick, and it is easier to spot them.

Equine Healthcare Market- Market Dynamics

Rising participation in equestrian sports

As more people get into riding horses, the equine healthcare market has benefited from this trend by putting more focus on horse health and performance. Since more individuals get involved in activities like racing, dressage, and show jumping, the need for specialized healthcare supplies and services grows. An increasing number of equestrian events and competitions require full healthcare plans for the horses that take part. This shows how this trend is growing. Because of this, the equine healthcare market is predicted to rise as owners put the health and performance of their horses first. According to the British Equestrian, there are 1.82 million regular and 3.2 million occasional riders, 850,000 horses, and a USD 6.6 bn industry value.

Equine Healthcare Market- Segmentation Analysis:

The worldwide market is segmented on the basis of product, indication, activity, distribution Channel, and region.

Based on the product, the pharmaceuticals segment is expected to capture the largest market share over the projected period. The market is rising because there is more demand for therapeutic, preventative, and specialty medications for horses. The market is growing quickly because more horse owners are aware of equine diseases, more people are willing to accept treatments prescribed by veterinarians, and more people are willing to accept treatments prescribed by veterinarians. Antibiotics, anti-inflammatory medications, painkillers, and immunizations are just a few of the numerous things that can make animals healthier and help them do better. Leading pharmaceutical companies put research and development, novel medicine formulations, and clever collaborations at the top of their lists of ways to grow their equine healthcare businesses. The market is seeing segmented revenue growth because biologics, regenerative therapies, and personalized treatments are always getting better.

Based on the indication, the parasitic infections segment dominates the market over the projected period. The high frequency of internal and external parasites in horse's fuel market growth. Effective parasiticides are still in high demand since parasites like strongyles, tapeworms, and ticks can cause serious health issues like colic, anemia, and weight loss. Long-acting medications, combination therapy, and better formulations are increasingly being used to improve convenience and efficacy.

Equine Healthcare Market- Geographical Insights

North America captures the majority of the market share in 2024 and will continue the same pattern during the forecast period. Welfare expenditures, riding horses, and improvements in diagnostics and regenerative therapies are all helping the industry grow. The region's growing rules and regulations for horse health and welfare are also expected to help the region thrive. The Animal and Plant Health Inspection Service (APHIS) of the United States Department of Agriculture (USDA) made the Horse Protection Regulations stronger in May 2024 to stop people from intentionally soring horses. Horse owners use this on purpose to injure their horses so they can do better in activities like racing, but it can be bad for the horse's health.

US Equine Healthcare Market- Country Insights

The US dominates the market in the region. This development is due to several causes, such as the expanding demand for advanced veterinary drugs, diagnostics, and software services, as well as horse owners, breeders, and equestrian sports participants being more aware of and taking steps to prevent problems. Furthermore, the growing acquisition of equine hospitals is expected to foster industry growth. For instance, in April 2025, Altano Group, a leading international network of equine clinics at the forefront of veterinary medicine, is thrilled to announce its acquisition of Del Oeste Equine Hospital.

Equine Healthcare Market- Competitive Landscape:

The market is rising because there is a growing need for therapeutic, preventative, and specialty drugs for horses. The market is developing swiftly because more horse owners know about horse diseases, more people are prepared to follow the advice of veterinarians, and more horses are getting sick. Antibiotics, anti-inflammatory medications, painkillers, and immunizations are just a few of the things that can help animals be healthier and do better. Top pharmaceutical companies put research and development, novel treatment formulations, and clever collaborations at the top of their lists to grow their equine healthcare businesses. The market is seeing segmented revenue growth because biologics, regenerative therapies, and tailored treatments are continually improving.

Recent Developments:

In March 2025, Altano Group, an internationally renowned network of leading equine veterinary clinics, announced a strategic partnership with Idaho Equine Hospital, a leading provider of western performance horse medicine and veterinary education. This collaboration further strengthens Altano's commitment to advancing equine healthcare globally.

In February 2025, in an exciting development within the equine veterinary community, Altano Group, an international leader in equine veterinary medicine, announced that Performance Equine Associates, a renowned full-service equine hospital and ambulatory practice located in Thackerville, Oklahoma, near the Texas state border, has joined the Altano Group.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EQUINE HEALTHCARE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arthrex Inc.
  • Zoetis Services LLC
  • Cargill
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Heska Corporation
  • Merck & Co. Inc
  • Esaote SPA
  • Dechra
  • Covetrus Inc.
  • Elanco
  • IDEXX Laboratories, Inc.
  • Equine Care Group
  • Boehringer Ingelheim Animal Health USA Inc.
  • Merck Animal Health

GLOBAL EQUINE HEALTHCARE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceuticals
  • Vaccines
  • Medicinal Feed Additives
  • Orthobiologics
  • Diagnostics
  • Software & Services
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Equine Herpes Virus
  • Musculoskeletal Disorders
  • Parasitic Infections
  • Equine Influenza
  • Equine Viral Arteritis (EVA)
  • Tetanus
  • West Nile Virus
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY ACTIVITY- MARKET ANALYSIS, 2019 - 2032

  • Sports/Racing
  • Recreation
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Hospitals & Clinics
  • Equestrian Facilities
  • E-commerce
  • Others

GLOBAL EQUINE HEALTHCARE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Equine Healthcare Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Equine Healthcare Market Snippet by Product
    • 2.1.2. Equine Healthcare Market Snippet by Indication
    • 2.1.3. Equine Healthcare Market Snippet by Activity
    • 2.1.4. Equine Healthcare Market Snippet by Distribution Channel
    • 2.1.5. Equine Healthcare Market Snippet by Country
    • 2.1.6. Equine Healthcare Market Snippet by Region
  • 2.2. Competitive Insights

3. Equine Healthcare Key Market Trends

  • 3.1. Equine Healthcare Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Equine Healthcare Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Equine Healthcare Market Opportunities
  • 3.4. Equine Healthcare Market Future Trends

4. Equine Healthcare Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Equine Healthcare Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Equine Healthcare Market Landscape

  • 6.1. Equine Healthcare Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Equine Healthcare Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024&2032 (%)
    • 7.1.2. Pharmaceuticals
    • 7.1.3. Vaccines
    • 7.1.4. Medicinal Feed Additives
    • 7.1.5. Orthobiologics
    • 7.1.6. Diagnostics
    • 7.1.7. Software & Services
    • 7.1.8. Others

8. Equine Healthcare Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024&2032 (%)
    • 8.1.2. Equine Herpes Virus
    • 8.1.3. Musculoskeletal Disorders
    • 8.1.4. Parasitic Infections
    • 8.1.5. Equine Influenza
    • 8.1.6. Equine Viral Arteritis (EVA)
    • 8.1.7. Tetanus
    • 8.1.8. West Nile Virus
    • 8.1.9. Others

9. Equine Healthcare Market - By Activity

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Activity, 2024&2032 (%)
    • 9.1.2. Sports/Racing
    • 9.1.3. Recreation
    • 9.1.4. Others

10. Equine Healthcare Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2024&2032 (%)
    • 10.1.2. Veterinary Hospitals & Clinics
    • 10.1.3. Equestrian Facilities
    • 10.1.4. E-commerce
    • 10.1.5. Others

11. Equine Healthcare Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Equine Healthcare Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.2.6. North America Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.2.8.5. U.S. Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.2.9.5. Canada Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Equine HealthcareKey Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.3.6. Europe Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.8.5. Germany Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.9.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.9.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.9.5. UK Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.10.5. France Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.11.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.11.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.11.5. Italy Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.12.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.12.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.12.5. Spain Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.13.6. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.14.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.14.5. Sweden Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.15.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.15.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.15.5. Russia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.16.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.16.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.16.5. Poland Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Equine HealthcareKey Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.4.6. APAC Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.8.5. China Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.9.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.9.5. India Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.10.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.10.5. Japan Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.11.5. South Korea Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.12.5. Australia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.14.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.14.5. Thailand Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.15.3. PhilippinesMarket Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.15.5. Philippines Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Equine Healthcare Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.5.6. LATAM Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.8.5. Brazil Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.9.5. Mexico Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.10.5. Argentina Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.11.5. Colombia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Equine HealthcareKey Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 11.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
    • 11.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 11.6.6. MEA Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.9. UAE
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.9.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.9.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.9.5. UAE Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.9.6. UAE Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.10.5. Israel Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.11.5. Turkey Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.12.5. Algeria Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.13.5. Egypt Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Billion)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Activity, 2019 - 2032 (US$ Billion)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Billion)

12. Key Vendor Analysis- Equine Healthcare Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arthrex Inc.
    • 12.2.2. Zoetis Services LLC
    • 12.2.3. Cargill
    • 12.2.4. Boehringer Ingelheim International GmbH
    • 12.2.5. Ceva Sante Animale
    • 12.2.6. Heska Corporation
    • 12.2.7. Merck & Co. Inc
    • 12.2.8. Esaote SPA
    • 12.2.9. Dechra
    • 12.2.10. Covetrus Inc.
    • 12.2.11. Elanco
    • 12.2.12. IDEXX Laboratories, Inc.
    • 12.2.13. Equine Care Group
    • 12.2.14. Boehringer Ingelheim Animal Health USA Inc.
    • 12.2.15. Merck Animal Health

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제